… studies to address the potential effects of long-acting bronchodilators on long-term outcomes,
such as disease progression and mortality. However, a substantial body of data on these …

… Long-acting bronchodilators are considered first line therapies for patients with COPD but
their effects on … the effects of long-acting bronchodilators on total mortality in stable COPD. …

… To explore the available evidence about the effects of long acting bronchodilators on
Health Related Quality of Life (HRQoL) and Health Status (HS) in clinical research. …

… relaxation, exerting potent, prolonged bronchodilator effects, that are to some extent additive.
Other beneficial effects of LABAs, mediated through their action on beta-adrenoreceptors in …

… effect might also be reduced by administration of effective long-acting bronchodilation (58).
The … of exacerbations through the reduction of lung hyperinflation by dual bronchodilation. …

… of long-acting bronchodilator drugs in an attempt to simplify treatment regimens as much as
possible. Consequently, several options for once-daily dual-action ultra … and this effect was …

… , long-acting bronchodilator therapy is advocated for regular use. Tiotropium is a newly
introduced long-acting … article discusses the use of long acting bronchodilators in COPD with a …

… During the first 6 weeks, 24 patients were randomized to the studygroup and received
treatment with a long-acting bronchodilator (LABD)(salmeterol xinafoate, 50 μg bid, via Diskus […

… Longacting bronchodilators have been shown to improve multiple clinical outcomes in …
large-scale clinical trials may also indicate a beneficial effect of long-acting bronchodilators …

… agonist or antimuscarinic/anticholinergic, alone or combined), durations of action and
speed of onset of bronchodilator effect. In the early stages of development of a maintenance …